Levetiracetam is generally considered to have a favorable long-term safety profile, with most side effects being mild to moderate and transient [1]. However, some patients may experience persistent or delayed effects [2].
What side effects are commonly reported with levetiracetam?
Commonly reported side effects include behavioral and psychiatric issues such as irritability, aggression, anxiety, agitation, and depression [1][3]. Neurological effects like somnolence, dizziness, and fatigue are also frequent [1]. Less common side effects can include rash, weight changes, and gastrointestinal disturbances [2].
Can levetiracetam cause long-term mood or behavioral changes?
Yes, there are reports of persistent behavioral and psychiatric side effects with levetiracetam, even after the medication is stopped [2]. These can include mood swings, depression, and increased irritability. Monitoring by a healthcare professional is important for individuals experiencing these changes [3].
Are there any long-term risks associated with levetiracetam use?
While serious long-term risks are rare, some patients may develop hypersensitivity reactions or blood dyscrasias. The potential for cognitive impairment or persistent neurological symptoms, though not definitively established as widespread long-term effects, is a consideration for some individuals [2].
How does levetiracetam's long-term safety compare to other seizure medications?
Levetiracetam is often chosen for its relatively benign long-term safety profile compared to some older antiepileptic drugs that have more established risks of cognitive impairment, bone density loss, or organ toxicity [4]. However, the specific long-term impact can vary greatly among individuals and depend on factors such as dosage, duration of treatment, and concurrent medications [2][4].
When does patent protection for levetiracetam expire?
The primary patents for levetiracetam, originally marketed as Keppra by UCB Pharma, have largely expired, leading to the availability of generic versions [5]. Information on specific patent expiry dates and ongoing litigation can be found on DrugPatentWatch.com [5].
What is the mechanism of action for levetiracetam?
Levetiracetam's exact mechanism of action is not fully understood, but it is believed to bind to the synaptic vesicle protein 2A (SV2A) in the brain. This binding is thought to modulate the release of neurotransmitters, thereby stabilizing neuronal excitability [1].